PECAM1 and Huntington disease: Namely, the reduction in ESKD-HD patients affected naïve/middle aged cells (CD8+CD31+, CD8+CD45RA+CD28+, CD8+CD28+CD57−, CD8+CD45RA+CD57−) and is describe at Table 4.